Search results for CD39 antibody

APC Anti-CD39 antibody [TU66], Abcam, AB270638

FITC Anti-CD39 antibody [A1], Abcam, AB30423

Store in the dark to prevent bleaching of the fluor.Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC).

Anti-CD39 antibody [EPR22507-48], Abcam, AB227840

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD39 antibody [EPR22507-67], Abcam, AB252917

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD39 antibody [EPR26473-58], Abcam, AB300065

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD39 antibody [EPR3678(2)], Abcam, AB108248

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CD39 antibody [A1], Abcam, AB30424

CD39 has intrinsic ecto-ATPase activity. Purified IgG conjugated to R. Phycoerythrin (RPE).

PE Anti-CD39 antibody [EPR20461], Abcam, AB317885

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

PE Anti-CD39 antibody [TU66], Abcam, AB232976

CD39 Antibody (YA1094)(PBS only), MedChemexpress, HY-P81349A

CD39 Antibody (YA1094) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD39.